Tiziana Life Sciences (TLSA) Assets Average (2018 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Assets Average of $14.0 million for Q4 2025, up 26.27% year-over-year from $11.1 million in Q4 2024, and up 0.76% quarter-over-quarter from $13.9 million in Q2 2025.
Tiziana Life Sciences (TLSA) Assets Average (2018 - 2025) Analysis & Trends
Tiziana Life Sciences' Assets Average history runs 8 years deep, the most recent figure standing at $14.0 million for Q4 2025.
- In Q4 2025, Assets Average rose 26.27% year-over-year to $14.0 million; the TTM figure through Dec 2025 stood at $14.0 million (up 26.27% YoY), while the FY2025 annual figure was $11.4 million, down 2.94% from the prior year.
- Assets Average for Q4 2025 stood at $14.0 million, up from $13.9 million in the prior quarter.
- The five-year high for Assets Average was $63.1 million in Q2 2021, with the low at $11.1 million in Q4 2024.
- The 5-year median for Assets Average is $18.4 million (2023), against an average of $27.7 million.
- The sharpest annual moves came in 2021 and 2023: Assets Average soared 722.16% in 2021, then slumped 51.95% in 2023.
- Tiziana Life Sciences' Assets Average stood at $53.3 million in 2021, then tumbled by 42.26% to $30.8 million in 2022, then tumbled by 51.95% to $14.8 million in 2023, then retreated by 24.84% to $11.1 million in 2024, then rose by 26.27% to $14.0 million in 2025.
- Business Quant data shows TLSA's Assets Average at $14.0 million in Q4 2025, $13.9 million in Q2 2025, and $11.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - | 14.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.05 Mn |
| Jun 30, 2025 | 13.94 Mn |
| Dec 31, 2024 | 11.12 Mn |
| Jun 30, 2024 | 11.57 Mn |
| Dec 31, 2023 | 14.80 Mn |
| Jun 30, 2023 | 21.95 Mn |
| Dec 31, 2022 | 30.80 Mn |
| Jun 30, 2022 | 41.98 Mn |
| Dec 31, 2021 | 53.35 Mn |
| Jun 30, 2021 | 63.11 Mn |
| Dec 31, 2020 | 40.69 Mn |
| Jun 30, 2020 | 7.68 Mn |
| Dec 31, 2019 | 2.51 Mn |
| Jun 30, 2019 | 4.85 Mn |
| Dec 31, 2018 | 4.39 Mn |
| Jun 30, 2018 | 2.11 Mn |